IDVOther than small business
IDC (single-award IDV) 75F40120D00032WE PHARMA, INC.
Overview
Award facts
- Obligated on orders under this IDV
- $2.56M
- $2,558,794 across 10 orders
- Period of performance
- From Sep 29, 2020
- Modifications
- 2
- Latest action May 16, 2022
- Contract type
- IDC (single-award IDV)
- PIID 75F40120D00032
Description of requirement
THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
Dates and value
- Award date
- Signed on Sep 29, 2020
- Ordering period ends
- Sep 29, 2025
- Ceiling
- Ceiling (single-award vehicle): $9,500,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 16, 2022. View on USAspending · Recipient on SAM.gov
Recipient
NameWE PHARMA, INC.
LocationMORRISVILLE, NC
UEIEWAMVJSFNK29
CAGE code7CN54
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyWE PHARMA, INC.
Business types and certifications
Minority-ownedFor-profit organizationLimited liability companyTax-exempt corporation
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Two stepTS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- FDASOL1222072
- Solicitation date
- Aug 4, 2020
- Notices
- Combined Synopsis/Solicitation posted Aug 4, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
Modification history
- Base award
- Sep 29, 2020
- Latest action
- May 16, 2022 — Other administrative actionModification P00002; administrative: no change in scope or value
- Latest substantive action
- Dec 1, 2021 — Supplemental agreement (within scope)Modification P00001
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Single awardS
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401